AR018952A1 - Una membrana o matriz para controlar la velocidad de penetracion de farmacos - Google Patents

Una membrana o matriz para controlar la velocidad de penetracion de farmacos

Info

Publication number
AR018952A1
AR018952A1 ARP990103082A ARP990103082A AR018952A1 AR 018952 A1 AR018952 A1 AR 018952A1 AR P990103082 A ARP990103082 A AR P990103082A AR P990103082 A ARP990103082 A AR P990103082A AR 018952 A1 AR018952 A1 AR 018952A1
Authority
AR
Argentina
Prior art keywords
membrane
matrix
elastomer
pharmacos
control
Prior art date
Application number
ARP990103082A
Other languages
English (en)
Original Assignee
Bayer Schering Pharma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Oy filed Critical Bayer Schering Pharma Oy
Publication of AR018952A1 publication Critical patent/AR018952A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10Block- or graft-copolymers containing polysiloxane sequences
    • C08L83/12Block- or graft-copolymers containing polysiloxane sequences containing polyether sequences
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Wrappers (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

Membrana matriz para controlar la velocidad de penetracion de un fármaco, en que dicha membrana o matriz comprende una composicion elastomérica basada ensiloxanos, que comprende por lo menos un elastomero y opcionalmente un polímero no reticulado.La composicion elastomérica comprende grupos de poli(oxido dealquileno), y los grupos de poli(oxido de alquileno) están presentes en el elastomero o en el polímero como injertos rematados por alcoxi de unidades depolisiloxanos, o como bloques,estando dichos injertos o bloques enlazados a las unidades de polisiloxanos por enlaces de silicio con carbono, o como unamezcla de estas formas. Métodos para la preparacion de un elastomero basado en siloxanos, que se ha de utilizar en dichamembrana o matr iz.
ARP990103082A 1998-06-30 1999-06-25 Una membrana o matriz para controlar la velocidad de penetracion de farmacos AR018952A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI981506A FI107339B (fi) 1998-06-30 1998-06-30 Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi

Publications (1)

Publication Number Publication Date
AR018952A1 true AR018952A1 (es) 2001-12-12

Family

ID=8552104

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103082A AR018952A1 (es) 1998-06-30 1999-06-25 Una membrana o matriz para controlar la velocidad de penetracion de farmacos

Country Status (28)

Country Link
EP (1) EP1124902B1 (es)
JP (1) JP2002519467A (es)
KR (1) KR100599868B1 (es)
CN (2) CN1176999C (es)
AR (1) AR018952A1 (es)
AT (1) ATE290049T1 (es)
AU (1) AU752895B2 (es)
BG (1) BG65148B1 (es)
BR (1) BR9911140B1 (es)
CA (1) CA2336149C (es)
CO (1) CO5060523A1 (es)
CZ (1) CZ299613B6 (es)
DE (1) DE69923992T2 (es)
EE (1) EE04685B1 (es)
ES (1) ES2237120T3 (es)
FI (1) FI107339B (es)
HU (1) HU229159B1 (es)
NO (1) NO327955B1 (es)
NZ (1) NZ508275A (es)
PE (1) PE20000935A1 (es)
PL (1) PL193485B1 (es)
PT (1) PT1124902E (es)
RU (1) RU2201794C2 (es)
SK (1) SK285325B6 (es)
TW (1) TWI237571B (es)
UA (1) UA71566C2 (es)
WO (1) WO2000000550A1 (es)
ZA (1) ZA200006986B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
EP1438942A1 (en) 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
WO2006026040A1 (en) * 2004-08-25 2006-03-09 Union Carbide Chemicals & Plastics Technology Corporation Polymeric film
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CA2675585C (en) 2007-03-12 2015-10-06 Bayer Schering Pharma Oy Use of tocopherol as a co-catalyst for ring opening polymerization of cyclic siloxanes
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
US20110166508A1 (en) 2008-09-17 2011-07-07 Lyytikaeinen Heikki inserter
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102008909B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CN102068914B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
TW201350122A (zh) 2012-04-23 2013-12-16 Bayer Pharma AG 18-甲基-15β,16β-亞甲基-19-降-20-螺氧-4-烯-3-酮的子宮內用途,包含18-甲基-15β,16β-亞甲基-19-降-20-螺氧-4-烯-3-酮的子宮內系統,及其於避孕及婦科治療之用途
PE20142437A1 (es) 2012-04-23 2015-01-31 Bayer Pharma AG Uso de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-onas en el tratamiento de menorragia, y sistemas intrauterinos que comprenden 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-onas para el tratamiento de trastornos con sangrado uterino
TN2016000134A1 (en) * 2013-10-18 2017-10-06 Bayer Oy Intrauterine delivery system.
CN108135910B (zh) 2015-05-13 2022-12-02 拜耳股份有限公司 长效药物递送装置及其在避孕中的用途
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
WO2019119059A1 (en) 2017-12-22 2019-06-27 Alyra Biotech Pty Ltd Treatment of pain and/or pain related symptoms associated with dysmenorrhea
ES2834450T3 (es) * 2018-03-05 2021-06-17 Evonik Operations Gmbh Copolímeros en bloques de poliéter-siloxano reticulados, así como su empleo para la producción de espumas de poliuretano
US20220233469A1 (en) 2019-05-31 2022-07-28 Alyra Biotech Pty Ltd Methods, compositions and devices for treating neuroinflammatory conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889108A (en) * 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers

Also Published As

Publication number Publication date
NO20006581L (no) 2000-12-29
FI981506A0 (fi) 1998-06-30
EP1124902B1 (en) 2005-03-02
ATE290049T1 (de) 2005-03-15
PE20000935A1 (es) 2000-09-18
ES2237120T3 (es) 2005-07-16
ZA200006986B (en) 2001-05-23
UA71566C2 (uk) 2004-12-15
BR9911140B1 (pt) 2009-08-11
HU229159B1 (hu) 2013-09-30
WO2000000550A1 (en) 2000-01-06
NZ508275A (en) 2002-09-27
BG65148B1 (bg) 2007-04-30
KR100599868B1 (ko) 2006-07-12
DE69923992T2 (de) 2006-04-13
AU752895B2 (en) 2002-10-03
FI981506L (fi) 1999-12-31
NO20006581D0 (no) 2000-12-21
SK285325B6 (sk) 2006-11-03
CA2336149A1 (en) 2000-01-06
KR20010053346A (ko) 2001-06-25
CZ20004749A3 (cs) 2001-10-17
SK18942000A3 (sk) 2001-07-10
EE04685B1 (et) 2006-08-15
CN1488678A (zh) 2004-04-14
CO5060523A1 (es) 2001-07-30
DE69923992D1 (de) 2005-04-07
PL193485B1 (pl) 2007-02-28
PT1124902E (pt) 2005-07-29
NO327955B1 (no) 2009-10-26
FI107339B (fi) 2001-07-13
RU2201794C2 (ru) 2003-04-10
CA2336149C (en) 2007-01-02
CN1176999C (zh) 2004-11-24
HUP0102600A3 (en) 2004-04-28
TWI237571B (en) 2005-08-11
HK1038939A1 (en) 2002-04-04
HUP0102600A2 (hu) 2001-11-28
EP1124902A1 (en) 2001-08-22
PL345103A1 (en) 2001-12-03
AU4783999A (en) 2000-01-17
EE200000788A (et) 2002-04-15
CN1269909C (zh) 2006-08-16
BG105081A (en) 2001-09-28
BR9911140A (pt) 2001-03-06
CN1308653A (zh) 2001-08-15
JP2002519467A (ja) 2002-07-02
CZ299613B6 (cs) 2008-09-17

Similar Documents

Publication Publication Date Title
AR018952A1 (es) Una membrana o matriz para controlar la velocidad de penetracion de farmacos
AR026647A1 (es) Dispositivo para el suministro de farmacos que tienen propiedades antiprogestinicas
PE20030316A1 (es) Sistema de suministro de dos o mas agentes terapeuticamente activos
PE20001019A1 (es) Nueva membrana o matriz para controlar la penetracion de farmacos
NO20056200L (no) Implanterbare, elastomere depotpreparater, anvendelser derav og fremgangsmate for fremstilling derav
CR8402A (es) Indazol-o-glucosidos sustitutos
NO20053849L (no) Otorhinologisk avleveringsinnretning
ATE554141T1 (de) Herstellung von silikon-kautschuk-elastomeren
AR037196A1 (es) Telas compuestas que tienen regiones polimericas elasticas discretas
ES2062632T3 (es) Composicion para tratamiento del cabello.
AR029464A1 (es) Metodos para el tratamiento de la diabetes
AR007203A1 (es) Un metodo para tratar una matriz de cemento endurecido, de ceramica, cemento hidraulico fraguado o agregados gruesos
ES2128500T3 (es) Polimeros y copolimeros dienicos con un grupo alcoxisilano.
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
BR0306993A (pt) Polìmero de polialquilenoglicol ativado; composição farmacêutica; método para tratar um paciente que tem uma infecção viral suscetìvel; e método para tratar um paciente suspeito de ter infecção por hepatite c
DE602005009373D1 (de) Härtbare organopolysiloxanzusammensetzung, härtungsverfahren dafür, halbleitervorrichtung und haftvermittler
CO7270455A2 (es) Composiciones que comprenden un agente de control biológico y un insecticida
ATE452939T1 (de) Elastomerblend
DE60231862D1 (de) Erodierbare polymere zur injektion
ES2192798T3 (es) Quinonadiimina como aditivo para el caucho.
PA8476201A1 (es) Mezclas de poliolefina y de poli (oxido de etileno) y proceso para hacer las mezclas.
DE602004005266D1 (de) Topische Zusammensetzung enthaltend ein Organopolysiloxan-Elastomer, sowie eine wässrige Dispersion eines Silikon-Block-Copolymers
FI3294300T3 (fi) Pitkävaikutteinen lääkkeenantolaite implantin tai kierukan muodossa, joka käsittää levonorgestreelia ja etinyyliestradiolia
ATE456393T1 (de) Haarfärbemittel enthaltend organosilikon- copolymere mit aminogruppen und polyoxyalkylengruppen sowie deren verwendung
ATE315064T1 (de) Polyorganosiloxan-zusammensetzung

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration